Literature DB >> 1089440

Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973.

H J Meuwissen, B Pollara, R J Pickering.   

Abstract

Fifty-five children with CID and known ADA status were studies at a workshop held in Albany, New York. Erythrocyte ADA determinations were performed in 22 of the 55 patients, 13 of whom were ADA negative. The ADA defect appears to be transmitted as an autosomal recessive trait. Some patients with CID and ADA deficiency have characteristic radiologic abnormalities of the skeleton, which are not found in other illnesses. The thymus glands of all patients with CID and ADA deficiency who could be examined have evidence of thymic involution manifested by presence of Hassall's corpuscles and differentiated germinal epithelium; this is in contrast to "classic" thymus findings in CID with normal ADA. Adenosine deaminase probably plays an important, although as yet undefined, role in lymphocyte development and/or function. The deficiency of ADA in CID is the first enzyme defect observed in a deficiency disease of specific immunity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1089440     DOI: 10.1016/s0022-3476(75)80463-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  46 in total

Review 1.  Short stature/short limb skeletal dysplasia with severe combined immunodeficiency and bowing of the femora: report of two patients and review.

Authors:  K D MacDermot; R M Winter; J S Wigglesworth; S Strobel
Journal:  J Med Genet       Date:  1991-01       Impact factor: 6.318

2.  Purine metabolism in lymphocytes from patients with primary hypogammaglobulinaemia.

Authors:  A D Webster; M North; J Allsop; G L Asherson; R W Watts
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

3.  Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  R P Agarwal; G W Crabtree; R E Parks; J A Nelson; R Keightley; R Parkman; F S Rosen; R C Stern; S H Polmar
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

4.  Adenosine deaminase activity in relation to the appearance of early and late Epstein-Barr virus antigens induced in lymphoblastoid cells.

Authors:  M Margalith; I Hendler
Journal:  Mol Cell Biochem       Date:  1991-12-11       Impact factor: 3.396

5.  Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.

Authors:  W P Schrader; B Pollara; H J Meuwissen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

Review 6.  Combined immunodeficiency and inborn errors of purine metabolism.

Authors:  H J Meuwissen; B Pollara
Journal:  Blut       Date:  1978-10-13

7.  Immunomorphological localization of adenosine deaminase in rat tissues during ontogeny.

Authors:  B E Chechik; S Sengupta; T Hibi; B Fernandes
Journal:  Histochem J       Date:  1985-02

8.  Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.

Authors:  T S Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

9.  Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.

Authors:  B S Mitchell; E Mejias; P E Daddona; W N Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

10.  Heterogeneity of stem cells in severe combined immunodeficiency.

Authors:  G S Incefy; E Grimes; W A Kagan; G Goldstein; E Smithwick; R O'Reilly; R A Good
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.